CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Gastric Cancer|Colon Cancer|Rectal Cancer|Esophageal Cancer|Pancreas Cancer|Lung Cancer|Breast Cancer
Interventions: BIOLOGICAL: CEA-targeted CAR-T cells|BIOLOGICAL: CEA-targeted CAR-T cells
Sponsor: Chongqing Precision Biotech Co., Ltd
Collaborators: Shanxi Bethune Hospital